Status | Study |
Recruiting |
Study Name: Biomarkers of Cytomegalovirus Fetal Infection and Disease Condition: Cytomegalovirus Congenital Date: 2017-01-03 Interventions: Biological: Bio-specimen collected |
Recruiting |
Study Name: Assesment of Olfactory Disorders and Performance of a New Olfactory Test in Children With Congenital CMV Condition: Congenital Cytomegalovirus Infection Date: 2016-05-23 Interventions: Other: olfactory tests, otoacoustic emissions (OAE) Two series of olfactory tests will be performed : 1) |
Recruiting |
Study Name: A Cross-sectional Study of Congenital Cytomegalovirus Infection in Newborns in China Condition: Congenital Cytomegalovirus Infection Date: 2016-03-05 |
Not yet recruiting |
Study Name: Myocardial Screening in Fetuses With Congenital Cytomegalovirus (CMV) Infection Condition: Disorder of Cardiac Function Date: 2016-02-18 Interventions: Device: echocardiographic examination Patients will underg |
Enrolling by invitation |
Study Name: Screening for Congenital Cytomegalovirus Infection in Newborns Condition: Cytomegalovirus Infections Date: 2016-02-11 Interventions: Other: Observation Viable Infants with a failed hearing screen or a diagnosis of SGA who are born at eit |
Recruiting |
Study Name: Cytomegalovirus Testing and Intervention Protocol for Newborn Nursery and Newborn Intensive Care Unit Condition: Congenital CMV Infection Date: 2016-02-08 Interventions: Other: Education of parents to pursue prompt hearing screening. Parents of patients will be counseled on |
Not yet recruiting |
Study Name: Evaluation of the Benefit of Antiviral Treatment With Valganciclovir on Congenital CMV Infection-related Deafness on Hearing and Balance Condition: Congenital Cytomegalovirus (CMV) Date: 2015-11-05 Interventions: Drug: Valganciclovir Oral valganciclovir (Rovalcyte 50 mg/ml, powder for oral suspension) at a dose of 1 |
Withdrawn |
Study Name: Safety, Tolerability, and Immunogenicity of a Cytomegalovirus DNA Vaccine Condition: Congenital Cytomegalovirus Infection Date: 2015-10-16 Interventions: Drug: CyMVectin CyMVectin will be delivered by unilateral intramuscular (IM) injection at Day 0, Day 28( |
Recruiting |
Study Name: A Cohort Study of Cytomegalovirus(CMV) Infection Among Pregnant Women and Their Newborns in China Condition: Congenital Cytomegalovirus Infection Cytomegalovirus Infection Date: 2015-07-31 |
Recruiting |
Study Name: Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregnancy Condition: Congenital Cytomegalovirus Infection Date: 2015-01-18 Interventions: Drug: Valacyclovir Drug: Placebo |